Virtus LifeSci Biotech Clinical Trials ETF
9 hedge funds and large institutions have $1.68M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$968K | |
| 2 | -$56.8K | |
| 3 | -$39.6K | |
| 4 |
DWS
Dynamic Wealth Strategies
Granite Bay,
California
|
-$22K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$13K |